drugset / Trial / NCT01352039

A Non-inferiority Study Comparing Two Heparin Sodium Preparations in Hip Fracture Surgery

NCT01352039

Phase 3 Terminated 544 enrolled Eurofarma Laboratorios S.A.
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The primary objective and endpoints of the study is compare the efficacy of two products containing heparin sodium, evaluating if the formulation produced by Eurofarma can be considered non-inferior to the reference product.

Timeline

Start
2011-10
Primary completion
2011-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Heparin Other / unclassified 5000 iu

Indications

No indication recorded.